Yokohama, Japan

Isao Sakano


Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Kanagawa, JP (1984)
  • Yokohama, JP (1984 - 1985)

Company Filing History:


Years Active: 1984-1985

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Isao Sakano: Innovator in Pharmaceutical Chemistry

Introduction

Isao Sakano is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. His work primarily focuses on the development of novel chemical compounds with potential therapeutic applications.

Latest Patents

Among his latest patents are the 2-Thiazolamine derivatives, which include a process for preparing these compounds. The disclosed 2-thiazol derivatives possess a general formula where R₁ and R₂ independently represent lower alkyl radicals with 1 to 4 carbon atoms. Additionally, X can represent various radicals, including lower alkyl, lower alkoxy, and halogenoalkoxy radicals. These derivatives have been noted for their immunomodulatory activity, making them valuable in pharmaceutical compositions. Another significant patent involves Uracil derivatives, which also includes a process for their preparation.

Career Highlights

Isao Sakano has worked with notable companies in the chemical industry, including Mitsui Toatsu Chemicals, Incorporated and Mitsui Toatsu Kagaki Kabushiki Kaisha. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical chemistry.

Collaborations

Throughout his career, Sakano has collaborated with esteemed colleagues such as Yutaka Okazaki and Hiroshi Tokuda. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Isao Sakano's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…